SCHEMBL24561

SCHEMBL24561

COc1ccc(-c2c(N)c(-c3ccc(OC)cc3)c(-c3ccc(OC)cc3)c(-c3ccc(N)cc3)c2-c2ccc(OC)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.67
MAPK1 P28482 1/20 0.67
ALDH1A1 P00352 3/20 0.64
CYP3A4 P08684 1/20 0.64
APP P05067 3/20 0.58
SMN1; SMN2 Q16637 3/20 0.55
NPC1 O15118 2/20 0.55
TP53 P04637 2/20 0.55
HPGD P15428 2/20 0.55
KDM4E B2RXH2 1/20 0.55
MAPT P10636 1/20 0.55
NFKB1 P19838 1/20 0.55
RAB9A P51151 1/20 0.55
NFKB2 Q00653 1/20 0.55
RELA Q04206 1/20 0.55
HSD17B10 Q99714 1/20 0.55
NR4A1 P22736 1/20 0.53
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8097613 0.91 TDP1 (0.56) TDP1MAPK1ALDH1A1CYP3A4APP
SCHEMBL1926936 0.84 TDP1 (0.84) TDP1MAPK1ALDH1A1CYP3A4APP
SCHEMBL9330651 0.82 CYP3A4 (0.59) TDP1MAPK1ALDH1A1CYP3A4APP
SCHEMBL8526630 0.82 TDP1 (1.00) TDP1MAPK1ALDH1A1CYP3A4APP
SCHEMBL5097 0.82
SCHEMBL20323072 0.82 CA1 (0.69) TDP1MAPK1ALDH1A1CYP3A4APP
SCHEMBL357435 0.79 TDP1 (0.94) TDP1MAPK1ALDH1A1CYP3A4APP
SCHEMBL5601373 0.79 TDP1 (0.94) TDP1MAPK1ALDH1A1CYP3A4APP
SCHEMBL21840887 0.79 TDP1 (0.94) TDP1MAPK1ALDH1A1CYP3A4APP
Methane SCHEMBL22289589 0.79 TDP1 (0.94) TDP1MAPK1ALDH1A1CYP3A4APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11870004-B2 Metal oxide nanoparticles surface-treated with metal ion, quantum dot-light-emitting device comprising the same and method for fabricating the same HONGIK UNIVERSITY INDUSTRY-ACADEMIA COOPERATION FOUNDATION (KR) 2024-01-09 US claimed
US-11186770-B2 II-VI based non-Cd quantum dots, manufacturing method thereof and QLED using the same HONGIK UNIVERSITY INDUSTRY-ACADEMIA COOPERATION FOUNDATION (KR) 2021-11-30 US claimed
US-20200362240-A1 II-VI BASED NON-Cd QUANTUM DOTS, MANUFACTURING METHOD THEREOF AND QLED USING THE SAME HONGIK UNIVERSITY INDUSTRY-ACADEMIA COOPERATION FOUNDATION (KR) 2020-11-19 US claimed
EP-2478576-B9 ORGANIC ELECTRONIC DEVICE AND DOPANT FOR DOPING AN ORGANIC SEMICONDUCTING MATRIX MATERIAL OSRAM OLED GMBH (DE) 2017-09-06 EP claimed
EP-2478576-B1 ORGANIC ELECTRONIC DEVICE AND DOPANT FOR DOPING AN ORGANIC SEMICONDUCTING MATRIX MATERIAL OSRAM OLED GMBH (DE) 2017-05-31 EP claimed
US-8933438-B2 Photodiode SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-01-13 US claimed
US-20130105768-A1 PHOTODIODE SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-05-02 US claimed
EP-3724181-B1 ORGANIC MOLECULES WITH A TRIFLUOROMETHYL-BIPHENYL CORE FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO LTD (KR) 2026-01-28 EP disclosed
EP-3880672-B1 CARBAZOLE DERIVATIVES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO LTD (KR) 2024-10-23 EP disclosed
US-20240215448-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO LTD (KR) 2024-06-27 US disclosed
US-11981848-B2 Quantum dots and electronic device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-05-14 US disclosed
US-11981850-B2 Quantum dots, and an electronic device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-05-14 US disclosed
EP-3472876-B1 CROSS-LINKING P-DOPANT FOR P-DOPING ORGANIC HOLE CONDUCTORS MERCK PATENT GMBH (DE) 2024-04-17 EP disclosed
EP-2304801-A1 STRUCTURE OF ELECTRO-OPTES Technische Universität Braunschweig (DE) 2011-04-06 EP disclosed
WO-2010079051-A1 SILYL AND HETEROATOM SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZO PHOSPHOLES AND THE APPLICATION THEREOF IN ORGANIC ELECTRONICS BASF SE (DE) 2010-07-15 WO disclosed
WO-2010040777-A1 SILOLES SUBSTITUTED WITH CONDENSED RING SYSTEMS AND USE THEREOF IN ORGANIC ELECTRONICS OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2010-04-15 WO disclosed
WO-2010010097-A1 STRUCTURE OF ELECTRO-OPTES TECHNISCHE UNIVERSITÄT BRAUNSCHWEIG (DE) 2010-01-28 WO disclosed
WO-2009089470-A2 PHOTOVOLTAIC DEVICES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2009-07-16 WO disclosed
WO-2009089472-A2 PHOTOVOLTAIC DEVICES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2009-07-16 WO disclosed
WO-2009049861-A1 ORGANIC ELECTROLUMINESCENT COMPONENT NOVALED AG (DE) 2009-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240215448-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES OR10J3, ORC3, MRPS23 TDP1 4559/4885MAPK1 4031/4885ALDH1A1 3570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.